A question for Tall_Allen, j-o-h-n, LearnAll, tango65 and a lot of other guys smarter than me.
In Aug 2019 I had a Radical prostatectomy. Nov 2019 I was dx with mCRPC and 6 bone lesions throughout my body.
I’ve run the gambit of Bicalutamide, Docetaxel, Abiraterone, Cabazitaxel, still taking Lupron and Zometa.
At the beginning of June I started Enzalutamide (Xtandi) 4x40 mg. After about a month I started having issues with fatigue, loss of appetite, nausea and dizziness.
On July 7 I called my doc and stopped taking Xtandi and I started feeling better a few days later.
On July 12, yesterday, I had my first Pluvicto (lutetium Lu 177) treatment and other than a little nausea and fatigue I feel fine.
Here’s my question, my oncologist wants to re-start me on the Xtandi at a 2x40 mg rate. Does this make sense?
Thanks in advance for everyone that responds.